Abstract
Some novel N-(benzo[d]thiazol-2-yl)-2-((4-(4-(m-tolyloxy)quinazolin-2yl)phenyl)amino)acetamides analogs (7a-j) have been synthesized. The synthetic approach exploits a consolidated protocol based on Suzuki coupling reaction on quinazoline ring. The analogs were tested for microbiological activity against eight bacteria (Staphylococcus aureus MTCC 96, Bacillus cereus MTCC 619, Escherichia coli MTCC 739, Pseudomonas aeruginosa MTCC 741, Klebsiella pneumoniae MTCC 109, Salmonella typhi MTCC 733, Proteus vulgaris MTCC 1771 and Shigella flexneri MTCC 1457) and four fungi (Aspergillus niger MTCC 282, Aspergillus fumigatus MTCC 343, Aspergillus clavatus MTCC 1323, and Candida albicans MTCC 183). Some of the synthesized analogs have demonstrated excellent antimicrobial activity (MICs: 3.12-25 μg/mL) as compared with the standards (MICs: 6.25-25 μg/mL). Density Functional Theory (DFT) calculations at the B3LYP/6-31G(d,p) level were performed to predict the molecular structure and electronic properties of the analogs. Further, the binding orientations of the potent analogs were validated by molecular docking studies.
Keywords: Quinazoline, Suzuki coupling, Antimicrobial activity, Molecular docking and DFT.
Letters in Drug Design & Discovery
Title:Design, Synthesis and Computational Studies of New Benzothiazole Substituted Quinazolines as Potential Antimicrobial Agents
Volume: 10 Issue: 10
Author(s): Amit B. Patel, Premlata Kumari, Suban K. Sahoo and Kishor H. Chikhalia
Affiliation:
Keywords: Quinazoline, Suzuki coupling, Antimicrobial activity, Molecular docking and DFT.
Abstract: Some novel N-(benzo[d]thiazol-2-yl)-2-((4-(4-(m-tolyloxy)quinazolin-2yl)phenyl)amino)acetamides analogs (7a-j) have been synthesized. The synthetic approach exploits a consolidated protocol based on Suzuki coupling reaction on quinazoline ring. The analogs were tested for microbiological activity against eight bacteria (Staphylococcus aureus MTCC 96, Bacillus cereus MTCC 619, Escherichia coli MTCC 739, Pseudomonas aeruginosa MTCC 741, Klebsiella pneumoniae MTCC 109, Salmonella typhi MTCC 733, Proteus vulgaris MTCC 1771 and Shigella flexneri MTCC 1457) and four fungi (Aspergillus niger MTCC 282, Aspergillus fumigatus MTCC 343, Aspergillus clavatus MTCC 1323, and Candida albicans MTCC 183). Some of the synthesized analogs have demonstrated excellent antimicrobial activity (MICs: 3.12-25 μg/mL) as compared with the standards (MICs: 6.25-25 μg/mL). Density Functional Theory (DFT) calculations at the B3LYP/6-31G(d,p) level were performed to predict the molecular structure and electronic properties of the analogs. Further, the binding orientations of the potent analogs were validated by molecular docking studies.
Export Options
About this article
Cite this article as:
B. Patel Amit, Kumari Premlata, K. Sahoo Suban and H. Chikhalia Kishor, Design, Synthesis and Computational Studies of New Benzothiazole Substituted Quinazolines as Potential Antimicrobial Agents, Letters in Drug Design & Discovery 2013; 10 (10) . https://dx.doi.org/10.2174/15701808113109990025
DOI https://dx.doi.org/10.2174/15701808113109990025 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Epigenetic Control Using Natural Products and Synthetic Molecules
Current Medicinal Chemistry The Role of Gut Microbiota in Antimicrobial Resistance: A Mini-Review
Anti-Infective Agents In vitro Synthesis, Structure Elucidation, and Antioxidant Properties of Platinum(IV)-hydrazide Complexes: Molecular Modeling of Free- Hydrazides Suggested as Potent Lipoxygenase Inhibitor
Medicinal Chemistry Emerging Antimicrobial Applications of Nitric Oxide (NO) and NO-Releasing Materials
Anti-Infective Agents in Medicinal Chemistry Chitosan: A Propitious Biopolymer for Drug Delivery
Current Drug Delivery Recent Patents and New Strategies in the Treatment of Psoriasis
Recent Patents on Anti-Infective Drug Discovery 4-Hydroxy-2-pyridone Derivatives and the δ-pyrone Isostere as Novel Agents Against Mycobacterium smegmatis Biofilm Inhibitors
Medicinal Chemistry Revision and Implementation of “Clinical Guideline for Tuberculosis and HIV in Prisons”, Great Tehran Prison, Iran
Infectious Disorders - Drug Targets Laccase Regulators in Anti-fungal Drug Discovery: Dark Lessons from the AIDS-related Pathogen, Cryptococcus
Current Enzyme Inhibition Noscapine-loaded PLA Nanoparticles: Systematic Study of Effect of Formulation and Process Variables on Particle Size, Drug Loading and Entrapment Efficiency
Pharmaceutical Nanotechnology Trends in Diagnosis for Active Tuberculosis Using Nanomaterials
Current Medicinal Chemistry Recent Advances in Computer-Aided Drug Design as Applied to Anti-Influenza Drug Discovery
Current Topics in Medicinal Chemistry The Role of Coagulation and Fibrinolysis in the Pathogenesis of Acute Lung Injury
Current Respiratory Medicine Reviews Preface:
Current Topics in Medicinal Chemistry Advancement in Vaccinology: New Era in Formulation Strategies
Current Drug Therapy Αlpha-2 Adrenergic and Opioids Receptors Participation in Mice Gastroprotection of Abelmoschus esculentus Lectin
Current Pharmaceutical Design Application of Metabolomics in Drug Discovery, Development and Theranostics
Current Metabolomics Nano Particles: Emerging Warheads Against Bacterial Superbugs
Current Topics in Medicinal Chemistry ATP Synthase Inhibitors as Anti-tubercular Agents: QSAR Studies in Novel Substituted Quinolines
Current Topics in Medicinal Chemistry Glycosylation Employing Unprotected Carbohydrate Acceptor Components
Current Organic Chemistry